249 related articles for article (PubMed ID: 20003083)
1. Polyneuropathy associated with IgM vs IgG monoclonal gammopathy: comparison between clinical and electrophysiological findings.
Vrethem M; Reiser N; Lauermann C; Svanborg E
Acta Neurol Scand; 2010 Jul; 122(1):52-7. PubMed ID: 20003083
[TBL] [Abstract][Full Text] [Related]
2. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.
Nobile-Orazio E; Manfredini E; Carpo M; Meucci N; Monaco S; Ferrari S; Bonetti B; Cavaletti G; Gemignani F; Durelli L
Ann Neurol; 1994 Sep; 36(3):416-24. PubMed ID: 8080249
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
Kuijf ML; Eurelings M; Tio-Gillen AP; van Doorn PA; van den Berg LH; Hooijkaas H; Stork J; Notermans NC; Jacobs BC
Neurology; 2009 Sep; 73(9):688-95. PubMed ID: 19720975
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
Garces-Sanchez M; Dyck PJ; Kyle RA; Zeldenrust S; Wu Y; Ladha SS; Klein CJ
Muscle Nerve; 2008 Apr; 37(4):490-5. PubMed ID: 18236455
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
Niermeijer JM; Fischer K; Eurelings M; Franssen H; Wokke JH; Notermans NC
Neurology; 2010 Feb; 74(5):406-12. PubMed ID: 20124206
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
7. Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases.
Magy L; Chassande B; Maisonobe T; Bouche P; Vallat JM; Léger JM
Eur J Neurol; 2003 Nov; 10(6):677-85. PubMed ID: 14641513
[TBL] [Abstract][Full Text] [Related]
8. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
Saito T
Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697
[TBL] [Abstract][Full Text] [Related]
9. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
11. The electrodiagnostic findings in polyneuropathies associated with IgM monoclonal gammopathies.
Kelly JJ
Muscle Nerve; 1990 Dec; 13(12):1113-7. PubMed ID: 1702520
[TBL] [Abstract][Full Text] [Related]
12. Length dependence in polyneuropathy associated with IgM gammopathy.
Franssen H; Notermans NC
Ann Neurol; 2006 Feb; 59(2):365-71. PubMed ID: 16437567
[TBL] [Abstract][Full Text] [Related]
13. Characterization of neuropathies associated with elevated IgM serum levels.
Goldfarb AR; Sander HW; Brannagan TH; Magda P; Latov N
J Neurol Sci; 2005 Feb; 228(2):155-60. PubMed ID: 15694197
[TBL] [Abstract][Full Text] [Related]
14. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
Irie S; Saito T; Kanazawa N; Ito H; Kowa H
Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
[TBL] [Abstract][Full Text] [Related]
15. [Anti-MAG paraproteinemic demyelinating polyneuropathy: a clinical, biological, electrophysiological and anatomopathological descriptive study of a 13-patients' cohort].
Launay M; Delmont E; Benaim C; Sacconi S; Butori C; Desnuelle C
Rev Neurol (Paris); 2009 Dec; 165(12):1071-9. PubMed ID: 19487003
[TBL] [Abstract][Full Text] [Related]
16. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
Lopate G; Choksi R; Pestronk A
Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
[TBL] [Abstract][Full Text] [Related]
17. Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.
El-Difrawy MM; Zaki NE; Marouf HM; Ayad MW; Farag AM
Int J Hematol; 2012 Jan; 95(1):71-6. PubMed ID: 22193843
[TBL] [Abstract][Full Text] [Related]
18. Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance.
Simmons Z; Bromberg MB; Feldman EL; Blaivas M
Muscle Nerve; 1993 Jan; 16(1):77-83. PubMed ID: 8380902
[TBL] [Abstract][Full Text] [Related]
19. Neuropathy associated with monoclonal gammopathies of undetermined significance.
Gosselin S; Kyle RA; Dyck PJ
Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
[TBL] [Abstract][Full Text] [Related]
20. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
